Published in Curr Opin Pulm Med on March 01, 2010
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
A comparison of muscle strength and endurance, exercise capacity, fatigue perception and quality of life in patients with chronic obstructive pulmonary disease and healthy subjects: a cross-sectional study. BMC Pulm Med (2014) 0.90
Comprehensive out-patient pulmonary rehabilitation: Treatment outcomes in early and late stages of chronic obstructive pulmonary disease. Ann Thorac Med (2011) 0.90
Superoxide release from contracting skeletal muscle in pulmonary TNF-α overexpression mice. Am J Physiol Regul Integr Comp Physiol (2013) 0.89
Effect of pulmonary TNF-α overexpression on mouse isolated skeletal muscle function. Am J Physiol Regul Integr Comp Physiol (2011) 0.88
Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy. Arthritis Res Ther (2012) 0.84
Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int (2014) 0.83
Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients. Int J Chron Obstruct Pulmon Dis (2015) 0.82
Effects of nutraceutical diet integration, with coenzyme Q10 (Q-Ter multicomposite) and creatine, on dyspnea, exercise tolerance, and quality of life in COPD patients with chronic respiratory failure. Multidiscip Respir Med (2013) 0.80
Inhibition of AMPK expression in skeletal muscle by systemic inflammation in COPD rats. Respir Res (2014) 0.79
Mitochondrial Dysfunction and Chronic Disease: Treatment With Natural Supplements. Integr Med (Encinitas) (2014) 0.77
Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease. BMC Complement Altern Med (2015) 0.77
MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD. COPD (2013) 0.76
Factors associated with impairment of quadriceps muscle function in Chinese patients with chronic obstructive pulmonary disease. PLoS One (2014) 0.75
In vitro effects of Beta-2 agonists on skeletal muscle differentiation, hypertrophy, and atrophy. World Allergy Organ J (2012) 0.75
Skeletal muscle alterations in HFrEF vs. HFpEF. Curr Heart Fail Rep (2017) 0.75
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med (2004) 18.60
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84
Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature (2002) 14.37
Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol (1961) 11.41
Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev (2003) 9.93
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ (2002) 7.07
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65
Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet (2005) 5.61
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet (2009) 5.51
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet (1996) 4.65
Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem (2005) 4.30
Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med (1996) 3.83
Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 3.69
Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 3.58
Systemic effects of chronic obstructive pulmonary disease. Eur Respir J (2003) 3.44
The molecular regulation of myogenesis. Clin Genet (2000) 3.34
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.09
Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med (1996) 3.05
Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis (1991) 2.95
Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J (2003) 2.80
Effect of pH on the kinetics of frog muscle phosphofructokinase. J Biol Chem (1966) 2.68
Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med (1990) 2.57
Lower limb activity and its determinants in COPD. Thorax (2008) 2.57
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax (2004) 2.54
Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 2.50
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax (1996) 2.33
Invited Review: redox modulation of skeletal muscle contraction: what we know and what we don't. J Appl Physiol (1985) (2001) 2.33
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 2.29
Short-term and long-term outcomes after bilateral lung volume reduction surgery : prediction by quantitative CT. Chest (2001) 2.26
Prolonged bed rest decreases skeletal muscle and whole body protein synthesis. Am J Physiol (1996) 2.26
Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J (1998) 2.25
Physical activity and hospitalization for exacerbation of COPD. Chest (2006) 2.24
Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J Immunol (2000) 2.14
Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med (1994) 2.12
Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1994) 2.06
Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.01
Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.01
Serum testosterone depression associated with hypoxia in respiratory failure. Clin Sci (Lond) (1980) 2.00
Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.97
Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax (2007) 1.94
Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.94
Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.91
Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis (1993) 1.87
Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.87
Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J (2004) 1.84
The molecular regulation of muscle stem cell function. Cold Spring Harb Symp Quant Biol (2009) 1.82
A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans. J Appl Physiol (1985) (2007) 1.80
Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax (1991) 1.79
Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc (1998) 1.77
The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.77
Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J (2006) 1.76
Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J Appl Physiol (1985) (2007) 1.76
Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1996) 1.70
Decrease in human quadriceps muscle protein turnover consequent upon leg immobilization. Clin Sci (Lond) (1987) 1.65
The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases. Clin Nutr (2002) 1.64
Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J (1997) 1.63
Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1996) 1.63
Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD. Thorax (2009) 1.62
Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J (2002) 1.60
Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest (2003) 1.54
Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J (1996) 1.43
Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.39
Molecular determinants of skeletal muscle mass: getting the "AKT" together. Int J Biochem Cell Biol (2005) 1.38
Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med (2000) 1.38
Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.38
Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax (2004) 1.38
Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.37
Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J (2002) 1.33
Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.33
Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax (2000) 1.33
Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.32
Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J (1994) 1.30
Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J (1990) 1.29
Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J (2003) 1.27
Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J (1997) 1.26
Cellular markers of muscle atrophy in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2009) 1.26
Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.26
Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med (1995) 1.25
Myosin heavy chain composition of skeletal muscles in young rats growing under hypobaric hypoxia conditions. J Appl Physiol (1985) (2000) 1.25
Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax (1997) 1.23
Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest (1998) 1.18
Effect of chronic hypoxia on muscle enzyme activities. Int J Sports Med (1990) 1.17
Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.16
Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet (1987) 1.15
Changes in skeletal muscles of young women with anorexia nervosa. An enzyme histochemical study. Acta Neuropathol (1982) 1.15
Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1996) 1.15
Reduced mechanical efficiency in chronic obstructive pulmonary disease but normal peak VO2 with small muscle mass exercise. Am J Respir Crit Care Med (2003) 1.15
NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax (2004) 1.14
Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J (1997) 1.14
Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol (1985) (1998) 1.14
Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med (2004) 1.14
Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J (2007) 1.13
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med (1998) 1.12
Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med (1991) 1.12
Increased content of hydrogen peroxide in the expired breath of cigarette smokers. Eur Respir J (1996) 1.11
Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax (2003) 1.11
Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2003) 1.10
Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med (1997) 1.10
A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res (2007) 1.10
Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial. Eur Respir J (2013) 1.57
Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration (2006) 1.47
Endurance exercise training improves heart rate recovery in patients with COPD. COPD (2013) 0.81
Nordic walking enhances oxygen uptake without increasing the rate of perceived exertion in patients with chronic obstructive pulmonary disease. Respiration (2015) 0.78
[Therapeutic strategies to increase the effectiveness of cough]. Rev Med Chil (2014) 0.75
Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev (2016) 0.75
Effectiveness of a Home-Based Active Video Game Programme in Young Cystic Fibrosis Patients. Respiration (2017) 0.75